Evidence map›Paper›PMID 36562915›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2025

Permanent pacing versus cardioneuroablation for cardioinhibitory vasovagal syncope.

Rakesh Gopinathannair, Brian Olshansky, Mohit K Turagam, Sandeep Gautam, Piotr Futyma, Krishna Akella, Halil Ibrahim Tanboga, Serdar Bozyel, Kivanc Yalin, Deepak Padmanabhan and 3 more

Abstract readMulticenter StudyComparative Study
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Cardioneuroablation versus cardiac pacemaker in the management of dominant cardioinhibitory vasovagal syncope: a retrospective cohort study.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  3. Convolutional neural network for real‑time localization of ganglionated plexi from bipolar intracardiac electrograms.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  4. Review
  5. Older age is not an independent predictor of syncope recurrence following cardioneuroablation for reflex syncope.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Observational
  6. Article
  7. Time for a paradigm shift: from pacing to ablation in reflex syncope.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  8. Different time course effect of autonomic nervous modulation after cryoballoon and hotballoon catheter ablations for paroxysmal atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  9. Intracardiac echocardiography and electroanatomical mapping: do we still need fluoroscopy for cardioneuroablation procedures?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  10. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Observational
  11. Quality of life improvement following cardioneuroablation for vasovagal syncope: expected or too early to say?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 4 countries.

Rakesh GopinathannairKansas City Heart Rhythm Institute and Research Foundation, 5100 W 110Th St, Ste 200, Overland Park, KS, 66211, USA. drrakeshg@yahoo.com.ORCID http://orcid.org/0000-0003-4611-3687
Brian OlshanskyUniversity of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Mohit K TuragamDepartment of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sandeep GautamDivision of Cardiovascular Medicine, University of Missouri-Columbia, Columbia, MO, USA.
Piotr FutymaMedical College, University of Rzeszów and St. Joseph's Heart Rhythm Center, Rzeszow, Poland.
Krishna AkellaHonor Health, Scottsdale, AZ, USA.
Halil Ibrahim TanbogaDepartment of Cardiology, Nisantasi University & Hisar Intercontinental Hospital, Istanbul, Turkey.
Serdar BozyelUniversity of Health Sciences, Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey.
Kivanc YalinDepartment of Cardiology, Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Deepak PadmanabhanSri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.
Jayaprakash ShentharSri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.
Dhanunjaya LakkireddyKansas City Heart Rhythm Institute and Research Foundation, 5100 W 110Th St, Ste 200, Overland Park, KS, 66211, USA.
Tolga AksuYeditepe University, Istanbul, Turkey.
Heart Rhythm Society · USSri Jayadeva Institute of Cardiovascular Sciences and Research · INHonorHealth · USIcahn School of Medicine at Mount Sinai · USİstanbul Nişantaşı Üniversitesi · TRIstanbul University-Cerrahpaşa · TRSağlık Bilimleri Üniversitesi · TRUniversity of Iowa Hospitals and Clinics · USUniversity of Missouri · USUniversity of Rzeszów · PLYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe compared the efficacy and safety of cardioneuroablation (CNA) vs. permanent pacing (PM) for recurrent cardioinhibitory vasovagal syncope (CI-VVS).

methodsOne hundred sixty-two patients (CNA = 61, PM = 101), age 36 + 11 years) with syncope frequency of 6.7 ± 3.9/year were included in this multicenter study. All patients with CNA were provided by a single center, while patients with PM were provided by 4 other centers. In the CNA arm, an electroanatomic mapping guided approach was used to detect and ablate ganglionated plexus sites. Dual chamber rate drop response (RDR) or close loop stimulation (CLS) transvenous and leadless pacemakers were implanted using standard technique. The primary endpoint was freedom from syncope.

resultsOf 101 patients in the PM group, 39 received dual-chamber pacemaker implants with the CLS algorithm, 38 received dual-chamber pacemakers with the RDR algorithm, and 24 received a leadless pacemaker. At 1-year follow-up, 97% and 89% in the CNA and PM group met the primary endpoint (adjusted HR = 0.27, 95% CI 0.06-1.24, p = 0.09). No significant differences in adverse events were noted between groups. There was no significant association between age (HR:1.01, 95% CI 0.96-1.06, p = 0.655), sex (HR:1.15, 95% CI 0.38-3.51, p = 0.809), and syncope frequency in the past year (HR:1.10, 95% CI 0.97-1.25, p = 0.122) and the primary outcome in univariable analyses.

conclusionsAfter adjustment for patient characteristics, the medium-term syncope recurrence risk of CI-VVS patients who underwent CNA was similar to that of a population of patients undergoing pacemaker implantation with a similar safety profile.

Indexed as

Cardiac Pacing, ArtificialCatheter AblationPacemaker, ArtificialSyncope, VasovagalAdultFemaleHumansMaleMiddle AgedTreatment OutcomeCardioneuroablationPacemakerVasovagal syncope

Identifiers

PMID36562915
OpenAlexW4312113476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.